EXONATE LIMITED

Active Cambridge

Manufacture of basic pharmaceutical products

9 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
E

EXONATE LIMITED

Manufacture of basic pharmaceutical products

Founded 5 Dec 2013 Active Cambridge, England 9 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 31 Dec 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 16 Jan 2026 Next due 19 Dec 2026 8 months remaining
Net assets £-6M £2M 2024 year on year
Total assets £1M £1M 2024 year on year
Total Liabilities £7M £310K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Wtl Moorfield Road Duxford Cambridge Cambridgeshire CB22 4PS England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for EXONATE LIMITED (08803638), an active life sciences and medical technology company based in Cambridge, England. Incorporated 5 Dec 2013. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£1.11M

Decreased by £901.04k (-45%)

Net Assets

-£5.61M

Decreased by £1.63M (-41%)

Total Liabilities

£6.83M

Increased by £309.65k (+5%)

Turnover

N/A

Employees

9

Decreased by 5 (-36%)

Debt Ratio

559%

Increased by 302 (+118%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (13)

Investor NameInvestor SinceParticipating Rounds
Investor 4Apr 2014Seed
Investor 5Apr 2014Seed
Investor 3Oct 2015Seed

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 24,042 Shares £1.70m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Nov 2021100£1£0.01
22 Jul 2021350£3.5£0.01
27 Mar 20192,468£200k£81
14 Jan 20191,100£12k£11
25 Sept 201811,823£958k£81

Officers

Officers

2 active 1 resigned
Status
Catherine Susan Minshull-beechDirectorBritishUnited Kingdom6830 Jan 2014Active
Rafiq HasanDirectorBritishEngland5713 May 2024Active

Shareholders

Shareholders (67)

Angel Cofund
11.2%
9,224
The University Of Nottingham
10.4%
8,614

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Mar 2026OfficersAppointment of Mr Phil Bates as director on 2026-03-05
18 Feb 2026OfficersTermination of Steven James Harper as director on 2026-02-13
16 Jan 2026Confirmation StatementConfirmation statement made on 2025-12-05 with updates
31 Dec 2025AccountsAnnual accounts made up to 2024-12-31
20 Dec 2024Confirmation StatementConfirmation statement made on 2024-12-05 with updates
10 Mar 2026 Officers

Appointment of Mr Phil Bates as director on 2026-03-05

18 Feb 2026 Officers

Termination of Steven James Harper as director on 2026-02-13

16 Jan 2026 Confirmation Statement

Confirmation statement made on 2025-12-05 with updates

31 Dec 2025 Accounts

Annual accounts made up to 2024-12-31

20 Dec 2024 Confirmation Statement

Confirmation statement made on 2024-12-05 with updates

Recent Activity

Latest Activity

Appointment of Mr Phil Bates as director on 2026-03-05

1 months ago on 10 Mar 2026

Termination of Steven James Harper as director on 2026-02-13

2 months ago on 18 Feb 2026

Confirmation statement made on 2025-12-05 with updates

3 months ago on 16 Jan 2026

Annual accounts made up to 2024-12-31

3 months ago on 31 Dec 2025

Confirmation statement made on 2024-12-05 with updates

1 years ago on 20 Dec 2024